MAGEA3 and neoplasm: The fraction of MoA-reacting T cells showed consistent binding to peptides homologous to MAGE-C2 (C2-BACT1, C2-BACT2, and C2-FIRM3) AND MAGE-A3/12 (A3/12-BACT1) in both tumor patients and HS.